Ledger.Open graph →
SEC Form D · filed July 1, 2015

Compass Therapeutics LLC

Offering
$121.0M
Sold
$16.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
HANOVER, NH
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Steve Tregay · HANOVER, NHDirectorErrik Anderson · HANOVER, NHExec · Director · PromoterThomas Schuetz · HANOVER, NHExec · Director · PromoterCarl Gordon · SAN FRANCISCO, CADirectorJulien Lagreze · PARIS, I0DirectorJay Yook · LOS ANGELES, CAExec · Director · PromoterCarl Gordon · Encinitas, CADirectorBen Auspitz · Bozeman, MTDirectorPhilip Ferneau · Portland, MEDirectorStephen Squinto · Woodbridge, CTDirectorJennifer Carolan · Palo Alto, CAExec · Director · PromoterJames E. Wiggins · Columbus, OHDirectorThomas Schuetz · Montreal, Quebec, CanadaExec · Director · PromoterCarl Gordon · CAMBRIDGE, MADirectorBen Auspitz · DURHAM, NCDirectorPhilip Ferneau · Portland, MEDirectorStephen Squinto · HANOVER, NHDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗